Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Morand Piert

Showing results (41-50 of 57) with videos related to

Pageof 6
Sort By:
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|June 3, 2006
Value of 11C-choline PET and contrast-enhanced CT for staging of bladder cancer: correlation with histopathologic findingsMaria Picchio, Uwe Treiber, Ambros J Beer, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|August 18, 2019
<sup>18</sup>F-Choline PET/mpMRI for Detection of Clinically Significant Prostate Cancer: Part 1. Improved Risk Stratification for MRI-Guided Transrectal Prostate BiopsiesMatthew S Davenport, Jeffrey S Montgomery, Lakshmi Priya Kunju, et al.
International Journal of Radiation Oncology, Biology, Physics|September 18, 2007
Hypoxia imaging with FAZA-PET and theoretical considerations with regard to dose painting for individualization of radiotherapy in patients with head and neck cancerAnca-Ligia Grosu, Michael Souvatzoglou, Barbara Röper, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|January 6, 2005
Hypoxia-specific tumor imaging with 18F-fluoroazomycin arabinosideMorand Piert, Hans-Jürgen Machulla, Maria Picchio, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 9, 2011
Concurrent temozolomide and dose-escalated intensity-modulated radiation therapy in newly diagnosed glioblastomaChristina I Tsien, Doris Brown, Daniel Normolle, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|March 18, 2017
Preclinical Evaluation of <sup>11</sup>C-Sarcosine as a Substrate of Proton-Coupled Amino Acid Transporters and First Human Application in Prostate CancerMorand Piert, Xia Shao, David Raffel, et al.
Nuclear Medicine and Biology|July 1, 2008
Tracking of [18F]FDG-labeled natural killer cells to HER2/neu-positive tumorsReinhard Meier, Morand Piert, Guido Piontek, et al.
Urology|April 26, 2022
Prostate Cancer With Peritoneal Carcinomatosis: A Robotic-assisted Radical Prostatectomy-based Case SeriesSteven B Goldenthal, Melissa A Reimers, Udit Singhal, et al.
Translational Andrology and Urology|July 18, 2020
Comparison of cross-sectional imaging techniques for the detection of prostate cancer lymph node metastasis: a critical reviewAmir H Lebastchi, Nikhil Gupta, John M DiBianco, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|November 4, 2018
Greater reduction in mid-treatment FDG-PET volume may be associated with worse survival in non-small cell lung cancerFeng-Ming Spring Kong, Ling Li, Weili Wang, et al.
Pageof 6

Showing results (41-50 of 57) with videos related to

Sort By:
Pageof 6
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|June 3, 2006
Value of 11C-choline PET and contrast-enhanced CT for staging of bladder cancer: correlation with histopathologic findingsMaria Picchio, Uwe Treiber, Ambros J Beer, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|August 18, 2019
<sup>18</sup>F-Choline PET/mpMRI for Detection of Clinically Significant Prostate Cancer: Part 1. Improved Risk Stratification for MRI-Guided Transrectal Prostate BiopsiesMatthew S Davenport, Jeffrey S Montgomery, Lakshmi Priya Kunju, et al.
International Journal of Radiation Oncology, Biology, Physics|September 18, 2007
Hypoxia imaging with FAZA-PET and theoretical considerations with regard to dose painting for individualization of radiotherapy in patients with head and neck cancerAnca-Ligia Grosu, Michael Souvatzoglou, Barbara Röper, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|January 6, 2005
Hypoxia-specific tumor imaging with 18F-fluoroazomycin arabinosideMorand Piert, Hans-Jürgen Machulla, Maria Picchio, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 9, 2011
Concurrent temozolomide and dose-escalated intensity-modulated radiation therapy in newly diagnosed glioblastomaChristina I Tsien, Doris Brown, Daniel Normolle, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|March 18, 2017
Preclinical Evaluation of <sup>11</sup>C-Sarcosine as a Substrate of Proton-Coupled Amino Acid Transporters and First Human Application in Prostate CancerMorand Piert, Xia Shao, David Raffel, et al.
Nuclear Medicine and Biology|July 1, 2008
Tracking of [18F]FDG-labeled natural killer cells to HER2/neu-positive tumorsReinhard Meier, Morand Piert, Guido Piontek, et al.
Urology|April 26, 2022
Prostate Cancer With Peritoneal Carcinomatosis: A Robotic-assisted Radical Prostatectomy-based Case SeriesSteven B Goldenthal, Melissa A Reimers, Udit Singhal, et al.
Translational Andrology and Urology|July 18, 2020
Comparison of cross-sectional imaging techniques for the detection of prostate cancer lymph node metastasis: a critical reviewAmir H Lebastchi, Nikhil Gupta, John M DiBianco, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|November 4, 2018
Greater reduction in mid-treatment FDG-PET volume may be associated with worse survival in non-small cell lung cancerFeng-Ming Spring Kong, Ling Li, Weili Wang, et al.
Pageof 6